In humans, Adamson and colleagues reported that a 72-hour fast lowered glucagon and epinephrine responses to hypoglycemia (35), and also lowered the need for exogenous glucose, which is not incompatible with our data. The gene discussed is GCG; the disease is Hypoglycemia.